MSIF - Latest guidance on MS and COVID19

Multiple Sclerosis International Federation global advice has just been updated. Find out about risk factors, prevention measures & advice on using different disease modifying therapies during the pandemic

This information reflects the latest research on COVID-19 and MS, including data presented at the MSVIRTUAL2020 conference.

The updated information includes:

  • Advice for people living with MS
  • Advice regarding disease modifying therapies (DMTs) for MS
  • Evidence on the impact of DMTs on COVID-19 severity
  • Advice regarding aHSCT
  • Seeking medical advice for relapse or other health concerns
  • Flu vaccine
  • COVID-19 vaccine
  • Advice for children or pregnant women living with MS

The latest information is available in full here: